CT-0525 is the first CAR-Monocyte to be evaluated in humans in the solid tumor setting First patient expected to be treated in the first half of 2024 "CT-0525 is the first CAR-Monocyte to be evaluated ...
PHILADELPHIA, June 25, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and developing ...
View today's Guangshen Railway Co Ltd stock price and latest 0525 news and analysis. Create real-time notifications to follow any changes in the live stock price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results